Experimental arthritis exacerbates Aggregatibacter actinomycetemcomitans-induced periodontitis in mice

J Clin Periodontol. 2012 Jul;39(7):608-16. doi: 10.1111/j.1600-051X.2012.01886.x. Epub 2012 May 14.

Abstract

Aim: This study aimed to investigate whether chronic antigen-induced arthritis (AIA) influences infection-induced periodontitis (PD) in mice and whether PD modifies the clinical course of AIA. The contribution of anti-TNF-α therapy was also evaluated.

Materials and methods: The PD was induced in C57BL/6 mice by oral infection with Aggregatibacter actinomycetemcomitans. AIA was induced after infection. Anti-TNF-α and chlorhexidine therapies were used to investigate the role of TNF-α and oral infection on PD and AIA interaction. Maxillae, knee joints, lymph nodes and serum samples were used for histomorphometric, immunoenzymatic and/or real time-PCR analyses.

Results: Antigen-induced arthritis exacerbated alveolar bone loss triggered by PD infection. In contrast, PD did not influence AIA in the evaluated time-points. PD exacerbation was associated with enhanced production of IFN-γ in maxillae and expression of the Th1 transcription factor tBET in submandibular lymph nodes. Increased serum levels of IL-6 and C-reactive protein were also detected. Anti-TNF-α and antiseptic therapies prevented the development and exacerbation of infectious-PD. Anti-TNF-α therapy also resulted in reduced expression of IFN-γ, TNF-α and IL-17 in maxillae.

Conclusions: Altogether, the current results indicate that the exacerbation of infection-induced PD by arthritis is associated with an alteration in lymphocyte polarization pattern and increased systemic immunoreactivity. This process was ameliorated by anti-TNF-α and antiseptic therapies.

MeSH terms

  • Acid Phosphatase / analysis
  • Actinobacillus Infections / drug therapy
  • Actinobacillus Infections / microbiology*
  • Aggregatibacter actinomycetemcomitans / physiology*
  • Alveolar Bone Loss / immunology
  • Alveolar Bone Loss / microbiology
  • Animals
  • Anti-Infective Agents, Local / therapeutic use
  • Arthritis, Experimental / drug therapy
  • Arthritis, Experimental / immunology*
  • Arthritis, Experimental / microbiology
  • C-Reactive Protein / analysis
  • Chlorhexidine / therapeutic use
  • Collagen Type I / immunology
  • Immunoglobulin G / blood
  • Interferon-gamma / analysis
  • Interleukin-17 / analysis
  • Interleukin-6 / blood
  • Isoenzymes / analysis
  • Lymph Nodes / pathology
  • Male
  • Maxilla / pathology
  • Mice
  • Mice, Inbred C57BL
  • Mice, Inbred Strains
  • Osteoclasts / pathology
  • Periodontitis / drug therapy
  • Periodontitis / immunology
  • Periodontitis / microbiology*
  • T-Box Domain Proteins / analysis
  • T-bet Transcription Factor
  • Tartrate-Resistant Acid Phosphatase
  • Tumor Necrosis Factor-alpha / antagonists & inhibitors

Substances

  • Anti-Infective Agents, Local
  • Collagen Type I
  • Immunoglobulin G
  • Interleukin-17
  • Interleukin-6
  • Isoenzymes
  • T-Box Domain Proteins
  • T-bet Transcription Factor
  • Tumor Necrosis Factor-alpha
  • Interferon-gamma
  • C-Reactive Protein
  • Acid Phosphatase
  • Tartrate-Resistant Acid Phosphatase
  • Chlorhexidine